A Phase II study of capecitabine plus cisplatin (plus trastuzumab) for previously untreated advanced gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 01 Aug 2017 Status changed from recruiting to discontinued.
- 03 Aug 2011 New trial record